Abstract
This presentation will review multiple topics currently generating significant speculation and discussion relevant to ASD. The topics will include cannabinoids, complementary and alternative medicine, vaccines, pharmacogenetic testing, prevalence data, potential environmental causes, social camouflaging in females, the use of artificial intelligence in diagnosis, terminology with respect to impacted individuals, polygenic risk factors, and the impact of the COVID-19 crisis on patients and families.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.